Aperam S.A.
APEMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,830,622 | $2,373,680 | $2,219,379 | $3,804,079 |
| - Cash | $216,000 | $443,000 | $457,000 | $524,000 |
| + Debt | $760,000 | $934,000 | $925,000 | $990,000 |
| Enterprise Value | $2,374,622 | $2,864,680 | $2,687,379 | $4,270,079 |
| Revenue | $6,255,000 | $6,592,000 | $8,156,000 | $5,102,000 |
| % Growth | -5.1% | -19.2% | 59.9% | – |
| Gross Profit | $449,000 | $330,000 | $1,180,000 | $1,233,000 |
| % Margin | 7.2% | 5% | 14.5% | 24.2% |
| EBITDA | $354,000 | $364,000 | $958,000 | $1,197,000 |
| % Margin | 5.7% | 5.5% | 11.7% | 23.5% |
| Net Income | $231,000 | $203,000 | $625,000 | $968,000 |
| % Margin | 3.7% | 3.1% | 7.7% | 19% |
| EPS Diluted | 3.17 | 2.79 | 8.29 | 12.17 |
| % Growth | 13.6% | -66.3% | -31.9% | – |
| Operating Cash Flow | $280,000 | $471,000 | $642,000 | $550,000 |
| Capital Expenditures | -$155,000 | -$301,000 | -$296,000 | -$152,000 |
| Free Cash Flow | $125,000 | $170,000 | $346,000 | $398,000 |